Alborch E, Salom J B, Perales A J, Torregrosa G, Miranda F J, Alabadí J A, Jover T
Centro de Investigación, Hospital Universitario La Fe, Valencia, Spain.
Eur J Pharmacol. 1992 Dec 8;229(1):83-9. doi: 10.1016/0014-2999(92)90289-g.
The isometric tension recorded from ring segments of branches of human middle cerebral artery was the parameter used to study the inhibition of spasmogen-induced contractions as model for cerebral vasospasm. Concentration-response curves to 5-hydroxytryptamine (10(-9)-3 x 10(-5) M) and prostaglandin F2 alpha (10(-7)-3 x 10(-5) M) were inhibited in Ca(2+)-free medium and in Ca(2+)-free medium to which EGTA (1 mM) had been added, respectively. Nimodipine (10(-7), 10(-5) M), nicardipine (10(-7), 10(-5) M) and Mg2+ (magnesium sulfate 10(-4), 10(-2) M) inhibited the 5-HT-elicited contractions, and this inhibition was similar for the highest concentrations tested. In contrast, nimodipine and nicardipine were more effective than Mg2+ to inhibit the prostaglandin F2 alpha-elicited contractions. Nimodipine (10(-9)-10(-5) M), nicardipine (10(-9)-10(-5) M) and Mg2+ (10(-5)-3 x 10(-2) M) relaxed the arteries precontracted with PGF2 alpha (10(-5) M), but nicardipine was the most potent relaxant drug. Because 5-hydroxytryptamine and prostaglandin F2 alpha may be involved in the pathogenesis of cerebral vasospasm, nimodipine, nicardipine, and Mg2+ could be used in the pharmacological treatment of this disorder. However, dihydropyridines (particularly nicardipine) are more potent anticonstrictors than Mg2+.
从人脑中动脉分支的环形节段记录的等长张力是用于研究作为脑血管痉挛模型的痉挛原诱导收缩抑制作用的参数。在无钙培养基和添加了EGTA(1 mM)的无钙培养基中,分别抑制了对5-羟色胺(10^(-9)-3×10^(-5) M)和前列腺素F2α(10^(-7)-3×10^(-5) M)的浓度-反应曲线。尼莫地平(10^(-7),10^(-5) M)、尼卡地平(10^(-7),10^(-5) M)和Mg2+(硫酸镁10^(-4),10^(-2) M)抑制了5-羟色胺引发的收缩,并且对于测试的最高浓度,这种抑制作用相似。相比之下,尼莫地平和尼卡地平在抑制前列腺素F2α引发的收缩方面比Mg2+更有效。尼莫地平(10^(-9)-10^(-5) M)、尼卡地平(10^(-9)-10^(-5) M)和Mg2+(10^(-5)-3×10^(-2) M)使预先用PGF2α(10^(-5) M)收缩的动脉舒张,但尼卡地平是最有效的舒张药物。由于5-羟色胺和前列腺素F2α可能参与脑血管痉挛的发病机制,尼莫地平、尼卡地平和Mg2+可用于该疾病的药物治疗。然而,二氢吡啶类(特别是尼卡地平)比Mg2+是更有效的抗收缩剂。